Myocardial Fibrosis among ART-treated Persons Living with HIV in South Africa
Abstract Background Heart failure is a prominent cardiovascular disease manifestation sub-Sarahan Africa. Myocardial fibrosis is a central feature of heart failure that we aimed to characterize among persons living with HIV (PWH) in South Africa (SA). Methods Cardiovascular magnetic resonance (CMR) imaging was performed among PWH with viral suppression and uninfected controls, both free of known CVD. Plasma levels of N-terminal pro B-type natriuretic peptide (NT-proBNP) were measured. Comparisons by HIV status were made using linear and logistic regression, adjusted for age, sex, and hypertension. Findings 134 PWH and 95 uninfected completed CMR imaging; age was 50 and 49 years, with 63% and 67% female, respectively. Compared to controls, PWH had greater myocardial fibrosis by extracellular volume fraction (ECV; absolute difference 1.2%; 95%CI 0.1-2.3). In subgroup analyses, the effect of HIV status on ECV was more prominent among women. Women (vs controls) were also more likely to have elevated NT-proBNP levels (>125 pg/mL; OR 2.4; 95%CI: 1.0-6.0). Among all PWH, an elevated NT-proBNP levels was associated with higher ECV (3.4% higher; 95%CI: 1.3-5.5). Interpretation HIV disease may contribute to myocardial fibrosis, with an effect more prominent among women. Research is needed to understand heart failure risk among PWH within sub-Saharan Africa.